C‐terminal fragment of amyloid precursor protein induces astrocytosis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
One of the pathophysiological features of Alzheimer's disease is astrocytosis around senile plaques. Reactive astrocytes may produce proinflammatory mediators, nitric oxide, and subsequent reactive oxygen intermediates such as peroxynitrites. In the present study, we investigated the possible role of the C‐terminal fragment of amyloid precursor protein (CT‐APP), which is another constituent of amyloid senile plaque and an abnormal product of APP metabolism, as an inducer of astrocytosis. We report that 100 n m recombinant C‐terminal 105 amino acid fragment (CT105) of APP induced astrocytosis morphologically and immunologically. CT105 exposure resulted in activation of mitogen‐activated protein kinase (MAPK) pathways as well as transcription factor NF‐κB. Pretreatment with PD098059 and/or SB203580 decreased nitric oxide (NO) production and nuclear factor‐kappa B (NF‐κB) activation. But inhibitors of NF‐κB activation did not affect MAPKs activation whereas they abolished NO production and attenuated astrocytosis. Furthermore, conditioned media derived from CT105‐treated astrocytes enhanced neurotoxicity and pretreatment with NO and peroxynitrite scavengers attenuated its toxicity. These suggest that CT‐APP may participate in Alzheimer's pathogenesis through MAPKs‐ and NF‐κB‐dependent astrocytosis and iNOS induction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
NF-kB: a crucial transcription factor for glial and neuronal cell function
O'Neill, L. A. J., & Kaltschmidt, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01035-1 · Cited by 1,013 · cited 1×
“…astrocytosis and iNOS expression in an NF-kB- and MAPK-dependent manner It has been well documented that the iNOS promoter has NF-kB response elements (Nathan and Xie 1994; Xie et al. 1994) and NF-kB is activated by various cellular stresses (Terai et al. 1996; O'Neill and Kaltschmidt 1997).”
BackgroundNeurodegenerative disorders: the role of peroxynitrite
Torreilles, F., Salman-Tabcheh, S., Guérin, M.-C., & Torreilles, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00014-4 · Cited by 430 · cited 2×
“Furthermore, peroxynitrite, a reaction product of NO, superoxide anion (O2 (2)) and a potent oxidative stress molecule, is known as a mediator of neuronal damage in the neurodegenerative diseases including AD (Torreilles et al. 1999).”
BackgroundAstrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease
DeWitt, D. A., Perry, G., Cohen, M., Doller, C., & Silver, J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6738 · Cited by 261
A morphological and morphometrical study of the retina in aging SAM mice
Shoji, M., Okada, M., Ohta, A., Higuchi, K., Hosokawa, M., & Honda, Y. (1998) · Ophthalmic Research · doi:10.1159/000055471 · Cited by 23
Cited by
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
“loid plaques in AD brain [106–108].”
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Self-citationNeuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433
“Ab stimulates a nuclear factor kappa B (NFjB)-dependent pathway that is required for cytokine gene transcription (Combs et al. 2001) within activated microglia and reactive astrocytes.”
BackgroundInfluentialContribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426
Metadata
- Authors
- Bach, J., Chae, H. S., Rah, J. C., Lee, M. W., Park, C. H., Choi, S. H., Choi, J. K., Lee, S. H., Kim, Y. S., Kim, K. Y., Lee, W. B., Suh, Y., & Kim, S. S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-07
- Volume
- 78
- Issue
- 1
- Pages
- 109-120
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2123405128
- Cited by
- 42
- References
- 6
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C‐terminal fragment of amyloid precursor protein induces astrocytosis. https://app.cochat.ai/papers/10.1046/j.1471-4159.2001.00370.x
- The paper
- Bach, J., Chae, H. S., Rah, J. C., Lee, M. W., Park, C. H., Choi, S. H., Choi, J. K., Lee, S. H., Kim, Y. S., Kim, K. Y., Lee, W. B., Suh, Y., & Kim, S. S. (2001). C‐terminal fragment of amyloid precursor protein induces astrocytosis. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2001.00370.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.